CD39+T regulatory cell reconstitution in MS patients with different CD39 gene polymorphisms undergoing autologous HSCT: A Preliminary Study

被引：0
|
作者：
Hendrawan, K. [1 ,2 ]
Ford, C. [1 ,2 ]
Khoo, M. [1 ,2 ]
Zaunders, J. [3 ,4 ]
Molloy, T. [1 ,2 ]
Ma, D. [1 ,2 ,5 ]
Moore, J. [2 ,5 ]
机构：
[1] St Vincents Ctr Appl Med Res, Blood Stem Cell & Canc Res Program, Sydney, NSW, Australia
[2] UNSW Sydney, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia
[3] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia
[4] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia
[5] St Vincents Hosp Sydney, Dept Haematol, Sydney, NSW, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 03期
关键词：
AHSCT; MS; CD39 gene polymorphism; Tregs;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：NP18 / NP18
页数：1
相关论文
共 37 条
  • [1] CD39+T REGULATORY CELLS AS A BIOMARKER OF IMMUNE RECONSTITUTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Yordanova, M. Nikolova
    Nikolova, M.
    Avramova, B.
    Konstantinov, D.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S26 - S26
  • [2] The role of CD39 and CD73 expressed by regulatory T cell in the pathogenesis of asthma in mice
    Dai, Ranran
    Wang, Linlin
    Shi, Guochao
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [3] LOW CD39 EXPRESSION MARKS SEVERE REGULATORY T CELL IMPAIRMENT IN PATIENTS WITH AUTOIMMUNE SCLEROSING CHOLANGITIS
    Grant, C. R.
    Liberal, R.
    Holder, B.
    Ma, Y.
    Mieli-Vergani, G.
    Vergani, D.
    Longhi, M. S.
    GUT, 2012, 61 : A119 - A119
  • [4] LOW CD39 EXPRESSION MARKS SEVERE REGULATORY T CELL IMPAIRMENT IN PATIENTS WITH AUTOIMMUNE SCLEROSING COLANGITIS
    Grant, C. R.
    Liberal, R.
    Holder, B.
    Ma, Y.
    Mieli-Vergani, G.
    Vergani, D.
    Longhi, M. S.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S370 - S370
  • [5] Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients
    Jin, Xi
    Zhang, Chenghui
    Gong, Lina
    Li, Huifang
    Wang, Yan
    Li, Qin
    Li, Hong
    JOURNAL OF DIABETES, 2019, 11 (06) : 440 - 448
  • [6] CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis
    Gupta, Vikas
    Katiyar, Shobhita
    Singh, Ankita
    Misra, Ramnath
    Aggarwal, Amita
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (08) : 1548 - 1556
  • [7] CD39 is overexpressed and has increased activity in regulatory T cells in patients with head and neck cancer
    Mandapathil, Magis
    Szczepansk, Miroslaw
    Czystowska, Malgorzata
    Szajnik, Marta
    Ren, Jin
    Jackson, Edwin
    Gorelik, Elieser
    Johnson, Jonas
    Lang, Stephan
    Whiteside, Theresa
    CANCER RESEARCH, 2009, 69
  • [8] CD39 expression by regulatory T cells participates in CD8+T cell suppression during experimental Trypanosoma cruzi infection
    Araujo Furlan, Cintia
    Boccardo, Santiago
    Rodriguez, Constanza
    Mary, Veronica
    Gimenez, Camila
    Robson, Simon
    Gruppi, Adriana
    Montes, Carolina
    Acosta Rodriguez, Eva
    PLOS PATHOGENS, 2024, 20 (04)
  • [9] Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis
    Zhang, H. Y.
    Yan, K. X.
    Huang, Q.
    Ma, Y.
    Fang, X.
    Han, L.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2015, 40 (02) : 182 - 191
  • [10] Regulatory T cells inhibit CD8 T cell proliferation in HIV-1 infection through CD39/adenosine pathway
    Nikolova, M.
    Carriere, M.
    Lelievre, J.
    Muhtarova, M.
    Bensussan, A.
    Levy, Y.
    RETROVIROLOGY, 2009, 6
1234